Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 12448731000202114 | Fostemsavir trometamol (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 12448741000202115 | Fostemsavir tromethamine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 12449741000202113 | Fostemsavir trometamol | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fostemsavir trometamol (substance) | Is a | Substance with Human immunodeficiency virus fusion inhibitor mechanism of action (substance) | true | Inferred relationship | Some | ||
| Fostemsavir trometamol (substance) | Is a | Piperazine and/or piperazine derivative (substance) | true | Inferred relationship | Some | ||
| Fostemsavir trometamol (substance) | Has disposition (attribute) | HIV fusion inhibitor | true | Inferred relationship | Some | ||
| Fostemsavir trometamol (substance) | Is modification of (attribute) | Fostemsavir | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fostemsavir (as fostemsavir trometamol) 600 mg prolonged-release oral tablet | Has precise active ingredient | True | Fostemsavir trometamol (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR